Likewise, in skin cancer, Par3 acts as a tumor suppressor or a tumor promoter depending on the tumor type; in keratoacanthoma it acts as a tumor suppressor, whereas it acts as a tumor promotor for melanoma (Nakamura et al., 2016). The gene discussed is PARD3; the disease is neoplasm.